SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $420 | +10.2% | 10 | 0.0% | 0.00% | – |
| Q4 2022 | $381 | – | 10 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 10 | -16.7% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 12 | -94.1% | 0.00% | – |
| Q4 2021 | $8,000 | – | 204 | +1940.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 10 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 10 | -80.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 50 | +316.7% | 0.00% | – |
| Q2 2019 | $2,000 | -50.0% | 12 | -53.8% | 0.00% | – |
| Q1 2019 | $4,000 | +100.0% | 26 | +44.4% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 18 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 18 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | 0.0% | 18 | -47.1% | 0.00% | – |
| Q2 2017 | $3,000 | +200.0% | 34 | +21.4% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 28 | -56.2% | 0.00% | – |
| Q2 2016 | $2,000 | – | 64 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |